Novartis AG is 48.8x more valuable than Liquidia Corp by market capitalization ($283.13 B vs $5.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LQDA | NVS |
|---|---|---|
| Market cap | $5.80 B | $283.13 B |
| US-listed rank | #1290 | #47 |
| Revenue (latest FY) | $158.32M | - |
| Net income (latest FY) | -$68.92M | - |
| Net margin | -43.5% | - |
| SEC filings | 628 | 947 |
Novartis AG is 48.8x more valuable than Liquidia Corp by market capitalization ($283.13 B vs $5.80 B).
Full pages: Liquidia Corp and Novartis AG, or browse the full rankings.